Science news articles about 'arthritis medication'

... of viral infections, such as herpes zoster, in patients with rheumatoid arthritis receiving these types of medications. Herpes zoster is one of the most common adverse events reported in clinical ...

Current arthritis medications can ease the pain, but stopping the progression of the disease requires more aggressive treatments: use of very limited available drugs or surgical intervention. ...

Use of certain medications known as monoclonal anti-tumor necrosis factor ± antibodies for the treatment of rheumatoid arthritis appears to be associated with an increased risk for herpes zoster, the ...

... , etanercept and infliximab are effective at reducing symptoms and slowing progression of rheumatoid arthritis (RA). These drugs act more quickly, require less laboratory monitoring, and are better ...

... for tuberculosis (TB) in patients with immune-mediated inflammatory diseases such as rheumatoid arthritis, ankylosing spondylitis, Crohn's disease, psoriatic arthritis and psoriasis. Most TB cases ...

... who have shown that AvrA reduces inflammation in the body, acting to some degree like new arthritis medications by reducing the activity of an inflammatory molecule known as NF-Kappa B. There are ...

LONDON, Nov. 24 (UPI) -- British drug regulators say they've agreed to review National Health Service restrictions on rheumatoid arthritis medications.

... the market. In the case of Vioxx, millions of people had already used the pain-killer and arthritis medication before researchers found it could increase the risk of having a heart attack or stroke. ...